OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Hematology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies	53
Structural organization of the bone marrow and its role in hematopoiesis	45
Mechanisms of immunothrombosis in COVID-19	38
Brothers in arms: platelets and neutrophils in ischemic stroke	35
Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease	34
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia	21
Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms	20
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes	19
Germline mutations in MDS/AML predisposition disorders	16
Biophysical and rheological biomarkers of red blood cell physiology and pathophysiology	16
Genetic heterogeneity and clonal evolution in acute myeloid leukemia	15
Recent advances in factor XII structure and function	15
The Nlrp3 inflammasome – the evolving story of its positive and negative effects on hematopoiesis	14
Current understanding of human megakaryocytic-erythroid progenitors and their fate determinants	14
The congenital dyserythropoieitic anemias: genetics and pathophysiology	13
Systems analysis of hematopoiesis using single-cell lineage tracing	13
Protein S: function, regulation, and clinical perspectives	12
Symmetric and asymmetric activation of hematopoietic stem cells	12
The N6-methyladenosine RNA modification in acute myeloid leukemia	12
Prothrombotic state associated with preeclampsia	12
Translational control by heme-regulated elF2α kinase during erythropoiesis	12
Ineffective erythropoiesis in sickle cell disease: new insights and future implications	11
Mouse models of vascular development and disease	11
VEXAS: where do we stand 2 years later?	11
Immunologic effects of red blood cell and platelet transfusions in neonates	11

The significance of CUX1 and chromosome 7 in myeloid malignancies	11
Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia	11
Human hematopoiesis: aging and leukemogenic risk	11
Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications	10
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	10
Cellular components of the hematopoietic niche and their regulation of hematopoietic stem cell function	10
Immunomodulatory roles of red blood cells	10
The protein C pathways	9
Blood in the water: recent uses of zebrafish to study myeloid biology	9
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis	9
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy	9
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies	9
Casting a NET on cancer: the multiple roles for neutrophil extracellular traps in cancer	9
Heterogeneity of fetal hemoglobin production in adult red blood cells	8
A zebrafish toolbox for biomechanical signaling in cardiovascular development and disease	8
Significance and management of isolated distal deep vein thrombosis	8
Regulation and importance of factor VIII levels in hemophilia A carriers	8
Complement contributions to COVID-19	8
Novel concepts in red blood cell clearance	7
Proteomic/transcriptomic analysis of erythropoiesis	7
Enhancing cardiovascular research with whole-organ imaging	7
Azacitidine maintenance in AML post induction and posttransplant	7
Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases	7
PIEZO1, sensing the touch during erythropoiesis	7
Therapeutic approaches targeting splicing factor mutations in myelodysplastic syndromes and acute myeloid leukemia	7
The impact of prenatal inflammation on hematopoietic development	7
Heterogeneity and origins of myeloid cells	6
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications	6
Studying clonal evolution of myeloid malignancies using induced pluripotent stem cells	6
Thrombosis in myeloproliferative neoplasms: update in pathophysiology	6
Hormetic endoplasmic reticulum stress in hematopoietic stem cells	6
Congenital neutropenia: disease models guiding new treatment strategies	6
Hidden behind thromboinflammation: revealing the roles of von Willebrand factor in sickle cell disease pathophysiology	6
Chediak-Higashi syndrome	6
Clonal hematopoiesis in hematopoietic stem cell transplantation	6
Erythrocyte pyruvate kinase activation in red cell disorders	6
Deciphering transcriptional and functional heterogeneity in hematopoiesis with single-cell genomics	6
Diverse functions of long noncoding RNAs in acute myeloid leukemia: emerging roles in pathophysiology, prognosis, and treatment resistance	6
Global perspectives on cellular therapy for children with sickle cell disease	6